Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 31, 2015 11:49 AM ET


Company Overview of ReVision Therapeutics, Inc.

Executive Profile

Jay B. Lichter Ph.D.

Chief Executive Officer, President, and Director, ReVision Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 different organizations across 14 different industries.

See Board Relationships


Dr. Jay B. Lichter, Ph.D. serves as a Managing Director and Partner of Avalon Ventures, LLC. Dr. Lichter has been with Avalon Ventures, LLC since 2007 and directs life sciences investing. He serves as Chief Executive Officer, Chairman since January 9, 2014, and Director of Avelas BioSciences Inc and COI Pharmaceuticals. Dr. Lichter is the Founder of Afraxis, Inc. He serves as the Chief Executive Officer and President of ReVision Therapeutics, Inc. He serves as the Chief ...

Corporate Headquarters

5626 Oberlin Drive
San Diego, California 92121

United States

Phone: 858-768-7860
Fax: 858-200-0821

Board Members Memberships

Founder and Chairman
Co-Founder and Chairman
Chief Executive Officer, President, and Director
Chief Executive Officer, President, and Director
Director, Chairman of Compensation Committee and Member of Audit Committee


PhD 1990
University of Illinois-Urbana-Champaign
BS 1984
University of Illinois-Urbana-Champaign
Post-Doctoral Training 1992
Yale University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ReVision Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at